Capacity & capability building for applied dementia research in low- & middle-income countries
Iracema Leroi(Trinity College Dublin), Nusrat Husain, Sridhar Vaitheswaran(Schizophrenia Research Foundation), Mohamed Sakel(East Kent Hospitals University NHS Foundation Trust), Sehrish Tofique(Pakistan Institute of Learning and Living), Nasim Chaudhry(Pakistan Institute of Learning and Living), Jahanara Miah(University of Manchester), S. P. Goswami(Dr. S.R. Chandrasekhar Institute of Speech and Hearing), Saima Sheikh(Imperial College London)
Cited by 15
Related Papers
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223
Impact of the COVID-19 Pandemic on Loneliness and Social Isolation: A Multi-Country Study
|International Journal of Environmental Research and Public Health|2021|208